These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1839137)

  • 21. Modulation of neuronal activity in the hippocampus by 5-hydroxytryptamine and 5-hydroxytryptamine1A selective drugs.
    Peroutka SJ; Mauk MD; Kocsis JD
    Neuropharmacology; 1987; 26(2-3):139-46. PubMed ID: 2884586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y; Yamawaki S
    Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
    De Vivo M; Maayani S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of centrally-active antihypertensives on 5-HT1A receptors in rat dorso-lateral septum, rat hippocampus and guinea-pig hippocampus.
    Leishman DJ; Boeijinga PH; Galvan M
    Br J Pharmacol; 1994 Jan; 111(1):318-24. PubMed ID: 8012713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo.
    Wilkinson LO; Middlemiss DN; Hutson PH
    J Pharmacol Exp Ther; 1994 Aug; 270(2):656-64. PubMed ID: 8071858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of buspirone differ from those of gepirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on unpunished responding of pigeons.
    Barrett JE; Fleck-Kandath C; Mansbach RS
    Pharmacol Biochem Behav; 1988 Jul; 30(3):723-7. PubMed ID: 2905470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
    Giral P; Martin P; Soubrié P; Simon P
    Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that 8-hydroxy-2-(n-dipropylamino)tetralin (8-OH-DPAT) is a selective alpha 2-adrenoceptor antagonist on guinea-pig submucous neurones.
    Crist J; Surprenant A
    Br J Pharmacol; 1987 Oct; 92(2):341-7. PubMed ID: 2890393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Nader MA; Barrett JE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA; Chou JM; Tang H; Frazer A
    J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats.
    Ramage AG; Fozard JR
    Eur J Pharmacol; 1987 Jun; 138(2):179-91. PubMed ID: 2957220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro.
    Van den Hooff P; Galvan M
    Br J Pharmacol; 1992 Aug; 106(4):893-9. PubMed ID: 1393288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
    Schoeffter P; Hoyer D
    J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different effects of 8-OH-DPAT, a 5-HT1A receptor agonist, on cortical acetylcholine release, electrocortigram and body temperature in guinea pigs and rats.
    Siniscalchi A; Beani L; Bianchi C
    Eur J Pharmacol; 1990 Jan; 175(2):219-23. PubMed ID: 2138087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.